You are here: Industry Insights > positive results

News List

AstraZeneca announces positive results for heart drug candidate biospectrumasia
August 21, 2019
DAPA-HF is the first heart failure outcomes trial with an SGLT2 inhibitor in patients with and without type-2 diabetes
Deciphera Announces Positive Results from Ripretinib Study americanpharmaceuticalreview
August 14, 2019
Deciphera Pharmaceuticals announced positive top-line data from the INVICTUS pivotal Phase 3 clinical study of ripretinib, a broad-spectrum KIT and PDGFRα inhibitor, in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors (GIST).
Leap Announces Positive Results for DKN-01, Keytruda Combination americanpharmaceuticalreview
August 08, 2019
Leap Therapeutics announced its anti-Dickkopf-1 (DKK1) antibody, DKN-01, in combination with Merck's anti-PD-1 antibody, Keytruda® (pembrolizumab), demonstrated higher survival and
Verona announces positive results for DPI form of COPD drug pharmaceutical-technology
August 06, 2019
UK-based Verona Pharma have announced the dry powdered inhaler (DPI) formulation of ensifentrine for chronic obstructive pulmonary disorder (COPD) has achieved all the endpoints in a Phase II trial.
Sumitomo Dainippon publishes positive results of schizophrenia drug pharmaceutical-technology
July 23, 2019
Japanese pharma company Sumitomo Dainippon has announced its drug Lonasen (blonanserin) has achieved its primary endpoint in a Phase III trial of 150 adolescents with schizophrenia.
Positive results for Novo’s Xultophy pharmatimes
June 11, 2019
“In clinical practice this becomes relevant as the longer a patient can remain in good control, the less exposure there is to high blood sugar, and the fewer escalations, or changes, in therapy are required.”
Positive results for Eli Lilly’s Taltz in late stage non-radiographic axial spondyloarthritis trial pharmatimes
April 24, 2019
Eli Lilly has announced that its humanised monoclonal antibody, Taltz (ixekizumab), yielded good results in a Phase III trial.
Aldeyra Therapeutics Announces Positive Results from Dry Eye Disease Clinical Trial americanpharmaceuticalreview
September 27, 2018
Aldeyra Therapeutics announced positive results from its Phase 2b clinical trial of topical ocular reproxalap in patients with dry eye disease.
Enteris BioPharma Announces Positive Results from Expanded Trial of Ovarest americanpharmaceuticalreview
June 27, 2018
Enteris BioPharma announced positive results today from the final treatment arm of the Phase 2a clinical trial of Ovarest
Researchers financed by pharma more likely to produce positive results, new report says pharmafile
January 19, 2017
Based on a sample of 195 drug effectiveness trials in 2013, it was found that 58% of lead authors had financial connections to the pharma industry.